Position in PRTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,591,556
+$1,631,995 QoQ
Shares Held
979,730
+19.6% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Derivatives in PRTA
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$278,832
PutShares
11,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. PRTA ranks #154 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in PRTA
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,591,556 | 979,730 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,959,561 | 818,885 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,932,429 | 935,333 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $3,447,436 | 353,221 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,206,920 | 528,323 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,316,966 | 510,462 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $7,707,884 | 556,526 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,947,784 | 415,289 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,226,682 | 350,130 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,651,130 | 308,887 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,129,782 | 333,786 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $12,078,083 | 250,323 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $13,153,116 | 192,635 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $10,909,481 | 225,077 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $13,017,313 | 216,055 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $16,160,137 | 266,537 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $7,335,495 | 270,184 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $9,455,648 | 258,563 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,577,329 | 214,116 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,406,996 | 75,909 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,766,501 | 73,264 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $278,832 | 11,100 | Put | Defined | 2021-05-17 | |
| 2021-03-31 | $12,450,250 | 495,631 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,407,621 | 450,260 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $133,311 | 11,100 | Put | Defined | 2021-02-12 | |
| 2020-09-30 | $5,142,382 | 514,753 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $382,617 | 38,300 | Put | Defined | 2020-11-13 | |
| 2020-06-30 | $400,618 | 38,300 | Put | Defined | 2020-08-12 | |
| 2020-06-30 | $4,457,277 | 426,126 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,377,358 | 409,099 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||